Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 8 studies | 24% ± 5% | |
microglial cell | 3 studies | 20% ± 1% |
Insufficient scRNA-seq data for expression of PLA2G15 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1538.69 | 653 / 653 | 100% | 17.34 | 604 / 605 |
skin | 100% | 1374.30 | 1809 / 1809 | 100% | 31.19 | 471 / 472 |
kidney | 100% | 2944.67 | 89 / 89 | 100% | 28.54 | 899 / 901 |
uterus | 100% | 712.08 | 170 / 170 | 99% | 16.55 | 456 / 459 |
prostate | 100% | 919.28 | 245 / 245 | 99% | 12.66 | 497 / 502 |
bladder | 100% | 859.95 | 21 / 21 | 99% | 18.55 | 498 / 504 |
breast | 100% | 1081.11 | 458 / 459 | 99% | 18.88 | 1107 / 1118 |
lung | 100% | 1650.96 | 578 / 578 | 99% | 16.21 | 1141 / 1155 |
brain | 99% | 1021.06 | 2607 / 2642 | 100% | 19.27 | 705 / 705 |
intestine | 100% | 795.49 | 966 / 966 | 99% | 14.11 | 520 / 527 |
esophagus | 99% | 635.84 | 1436 / 1445 | 99% | 12.77 | 181 / 183 |
adrenal gland | 100% | 1162.21 | 258 / 258 | 98% | 17.80 | 226 / 230 |
ovary | 99% | 779.11 | 178 / 180 | 99% | 16.29 | 425 / 430 |
stomach | 99% | 692.95 | 355 / 359 | 98% | 14.38 | 281 / 286 |
liver | 100% | 962.37 | 225 / 226 | 91% | 9.78 | 371 / 406 |
pancreas | 90% | 432.57 | 294 / 328 | 99% | 18.78 | 177 / 178 |
adipose | 100% | 1470.93 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 20.92 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.81 | 29 / 29 |
muscle | 100% | 3382.02 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2175.34 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.34 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.88 | 1 / 1 |
heart | 100% | 1960.26 | 858 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 935.98 | 1321 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 80% | 491.54 | 742 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006650 | Biological process | glycerophospholipid metabolic process |
GO_0006658 | Biological process | phosphatidylserine metabolic process |
GO_0006672 | Biological process | ceramide metabolic process |
GO_0034638 | Biological process | phosphatidylcholine catabolic process |
GO_0046338 | Biological process | phosphatidylethanolamine catabolic process |
GO_0009062 | Biological process | fatty acid catabolic process |
GO_0046470 | Biological process | phosphatidylcholine metabolic process |
GO_0006651 | Biological process | diacylglycerol biosynthetic process |
GO_0006644 | Biological process | phospholipid metabolic process |
GO_0046471 | Biological process | phosphatidylglycerol metabolic process |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0005764 | Cellular component | lysosome |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0008970 | Molecular function | phospholipase A1 activity |
GO_0008374 | Molecular function | O-acyltransferase activity |
GO_0052739 | Molecular function | phosphatidylserine 1-acylhydrolase activity |
GO_0052740 | Molecular function | 1-acyl-2-lysophosphatidylserine acylhydrolase activity |
GO_0005543 | Molecular function | phospholipid binding |
GO_0047499 | Molecular function | calcium-independent phospholipase A2 activity |
GO_0016411 | Molecular function | acylglycerol O-acyltransferase activity |
GO_0004622 | Molecular function | lysophospholipase activity |
GO_0102545 | Molecular function | phosphatidyl phospholipase B activity |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | PLA2G15 |
Protein name | Phospholipase A2 group XV (1-O-acylceramide synthase) (ACS) (LCAT-like lysophospholipase) (LLPL) (EC 3.1.1.5) (Lysophospholipase 3) (Lysosomal phospholipase A and acyltransferase) (EC 2.3.1.-, EC 3.1.1.32, EC 3.1.1.4) (Lysosomal phospholipase A2) (LPLA2) Phospholipase A2 group XV Phospholipase A2 group XV (EC 3.1.1.32) (EC 3.1.1.4) (EC 3.1.1.5) (1-O-acylceramide synthase) (LCAT-like lysophospholipase) (Lysophospholipase 3) (Lysosomal phospholipase A and acyltransferase) (Lysosomal phospholipase A2) |
Synonyms | LYPLA3 UNQ341/PRO540 |
Description | FUNCTION: Has dual calcium-independent phospholipase and O-acyltransferase activities with a potential role in glycerophospholipid homeostasis and remodeling of acyl groups of lipophilic alcohols present in acidic cellular compartments . Catalyzes hydrolysis of the ester bond of the fatty acyl group attached at sn-1 or sn-2 position of phospholipids (phospholipase A1 or A2 activity) and transfer it to the hydroxyl group at the first carbon of lipophilic alcohols (O-acyltransferase activity) . Among preferred fatty acyl donors are phosphatidylcholines, phosphatidylethanolamines, phosphatidylglycerols and phosphatidylserines . Favors sn-2 over sn-1 deacylation of unsaturated fatty acyl groups of phosphatidylcholines and phosphatidylethanolamines (By similarity). Among preferred fatty acyl acceptors are natural lipophilic alcohols including short-chain ceramide N-acetyl-sphingosine (C2 ceramide), alkylacylglycerols, monoacylglycerols, and acylethanolamides such as anandamide and oleoylethanolamide . Selectively hydrolyzes the sn-1 fatty acyl group of truncated oxidized phospholipids and may play a role in detoxification of reactive oxidized phospholipids during oxidative stress . Required for normal phospholipid degradation in alveolar macrophages with potential implications in pulmonary surfactant clearance (By similarity). At neutral pH, hydrolyzes the sn-1 fatty acyl group of the lysophosphatidylcholines . . |
Accessions | H3BMU8 ENST00000566188.5 ENST00000565744.5 H3BPT3 H3BM47 ENST00000564827.6 ENST00000444212.2 B4DPU0 H3BT70 ENST00000413021.2 [Q8NCC3-2] ENST00000568082.1 Q8NCC3 B4DJW4 ENST00000219345.10 [Q8NCC3-1] ENST00000566978.1 |